PB2678: THE PROGNOSTIC SIGNIFICANCE OF CONTROLLING NUTRITIONAL STATUS AND SARCOPENIA IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

PB2678: THE PROGNOSTIC SIGNIFICANCE OF CONTROLLING NUTRITIONAL STATUS AND SARCOPENIA IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

Bibliographic Details
Main Authors:	Se‑il Go, Sungwoo Park, Eun-Jeong Jeong, Gyeong-Won Lee
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000977388.39820.a1

Similar Items

Prognostic model based on the geriatric nutritional risk index and sarcopenia in patients with diffuse large B-cell lymphoma
by: Se-Il Go, et al.
Published: (2020-05-01)

The Endothelial Activation and Stress Index (EASIX) score is an independent prognostic factor in patients with diffuse large B-cell lymphoma
by: Sungwoo Park, et al.
Published: (2022-07-01)

Prognostic impact of pretreatment skeletal muscle index and CONUT score in diffuse large B-cell Lymphoma
by: Se-Il Go, et al.
Published: (2023-11-01)

Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B‐cell lymphoma
by: Se‐Il Go, et al.
Published: (2021-12-01)

Lipocalin‐2 as a prognostic biomarker and its association with systemic inflammation in small cell lung cancer
by: Se‐Il Go, et al.
Published: (2024-07-01)

Perbandingan Antara Klon Teh Gpps-I/2678 DanTRI-2025 Comparisaon between GPPS-1/2678 and TRI-2023 Tea Clones
by: Perpustakaan UGM, i-lib
Published: (2002)

PB2313: THE PROGNOSTIC SIGNIFICANCE OF APOPTOSIS-INDUCING FACTOR IN DIFFUSE LARGE B-CELL LYMPHOMA
by: Elena Vaneeva, et al.
Published: (2023-08-01)

Prognostic significance of BLK expression in R-CHOP treated diffuse large B-cell lymphoma
by: Soyeon Choi, et al.
Published: (2022-09-01)

PB2164: PROGNOSTIC IMPACT OF ONCOGENE DEK IN DIFFUSE LARGE B-CELL LYMPHOMA
by: R. Alonso Alonso, et al.
Published: (2022-06-01)

Prognostic significance of CDK1 expression in diffuse large B-Cell lymphoma
by: Qiuni Chen, et al.
Published: (2025-01-01)

PROGNOSTIC SIGNIFICANCE OF LMR AND RDW IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA
by: CA Assis, et al.
Published: (2023-10-01)

Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma
by: Ting-Xun Lu, et al.
Published: (2019-06-01)

Risk factors for postoperative haemorrhage after total thyroidectomy: clinical results based on 2,678 patients
by: Xu Zhang, et al.
Published: (2017-08-01)

Prognostic Significance of in situ Phenotypic Marker Expression in Diffuse Large B-cell Lymphomas
by: Alexandar Tzankov, et al.
Published: (2007-01-01)

Prognostic significance of helicobacter pylori-infection in gastric diffuse large B-cell lymphoma
by: Yuan Cheng, et al.
Published: (2019-08-01)

Expression and Prognostic Significance of PD-L2 in Diffuse Large B-Cell Lymphoma
by: Qianhui Gu, et al.
Published: (2021-06-01)

Prognostic Significance of Sarcopenia in Advanced Biliary Tract Cancer Patients
by: Byung min Lee, et al.
Published: (2020-09-01)

PB2354: DIFFUSE LARGE B CELL LYMPHOMA IN 65: DIAGNOSTIC, PROGNOSTIC, PROGRESSIVE AND THERAPEUTIC ASPECTS
by: Zaineb Mlayah, et al.
Published: (2023-08-01)

Prognostic Nutritional Index Predicts Early Mortality in Diffuse Large B-cell Lymphoma
by: Erman OZTURK, et al.
Published: (2022-03-01)

Prognostic significance of CT-determined sarcopenia in patients with advanced gastric cancer.
by: Jong Soo Lee, et al.
Published: (2018-01-01)

Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease
by: Goh Eun Chung, et al.
Published: (2019-06-01)

Clinical Features and Prognostic Significance of NOTCH1 Mutations in Diffuse Large B-Cell Lymphoma
by: Zhongqi Li, et al.
Published: (2021-12-01)

PB2093: DIFFUSE LARGE B CELL LYMPHOMA IN THE ELDERLY
by: G. Abichou, et al.
Published: (2022-06-01)

Prognostic nutritional index and the prognosis of diffuse large b-cell lymphoma: a meta-analysis
by: Chunyan Luan, et al.
Published: (2020-09-01)

The prognostic impact of comorbidity, nutritional and performance status on patients with diffuse large B cell lymphoma
by: B. Saglam, et al.
Published: (2020-10-01)

The prevalence and prognostic significance of Sarcopenia and Adipopenia in Pleural Mesothelioma
by: Andrew C. Kidd, et al.
Published: (2024-01-01)

PB2342: PROGNOSTIC SIGNIFICANCE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO, PLATELET/LYMPHOCYTE RATIO AND SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
by: Ons Charef, et al.
Published: (2023-08-01)

Spatially-resolved transcriptomics reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphoma
by: Liu, Min, et al.
Published: (2024)

Spatially-resolved transcriptomics reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphoma
by: Min Liu, et al.
Published: (2024-03-01)

Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication
by: Yu-Jia Huo, et al.
Published: (2022-03-01)

Prognostic significance of neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma: A meta-analysis.
by: Jin Wang, et al.
Published: (2017-01-01)

Prognostic Significance of MiRNA in Patients with Diffuse Large B-Cell Lymphoma: a Meta-Analysis
by: Zhuojun Zheng, et al.
Published: (2016-10-01)

Clinical Analysis and Prognostic Significance of Hepatitis B Virus Infections with Diffuse Large B-Cell Lymphoma
by: Kang X, et al.
Published: (2020-04-01)

PB2353: PROGNOSTIC VALUE OF TIME FROM SYMPTOMS BEGIN TO START TREATMENT IN DIFFUSE LARGE B-CELL LYMPHOMA
by: Sunil Lakhwani Lakhwani, et al.
Published: (2023-08-01)

Corrigendum to database on the mechanical properties of high entropy alloys and complex concentrated alloys, data in brief 21 (2018) 2664–2678
by: S. Gorsse, et al.
Published: (2020-10-01)

Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)
by: Kim Yu, et al.
Published: (2012-08-01)

Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma: a meta-analysis
by: Ju-Han Lee, et al.
Published: (2017-05-01)

A Novel Inflammatory-Nutritional Prognostic Scoring System for Patients with Diffuse Large B Cell Lymphoma
by: Wang Z, et al.
Published: (2024-01-01)

Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma
by: Jeayeon Park, et al.
Published: (2023-07-01)

Prognostic evaluation of system immune-inflammatory index and prognostic nutritional index in double expressor diffuse large B-cell lymphoma
by: Su Fang, et al.
Published: (2023-10-01)